共 50 条
- [42] Re: Cumulative Burden of Morbidity among Testicular Cancer Survivors after Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study Editorial Comment JOURNAL OF UROLOGY, 2019, 201 (01): : 32 - 33
- [44] Re: Multi-Institutional Assessment of Adverse Health Outcomes among North American Testicular Cancer Survivors after Modern Cisplatin-Based Chemotherapy JOURNAL OF UROLOGY, 2018, 199 (01): : 29 - 29
- [46] Re: The Cardiac Impact of Cisplatin-Based Chemotherapy in Survivors of Testicular Cancer: A 30-Year Follow-up EDITORIAL COMMENT JOURNAL OF UROLOGY, 2022, 208 (05): : 1162 - 1162